Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.
The 3.8 Initiative, named for the March 8 International Women's Day, seeks to increase start-up board leadership for women in the Connecticut area's life science and health tech innovation ecosystem.
The three key pillars of the program include:
Each cohort participates in several workshops and engages with subject matter experts outlining content relevant to startup board governance and leadership seminars.
Our Curriculum Focus
Who Should Apply?
A pre-requisite for the program is a WIB membership. To learn more, contact the Connecticut chapter at: connecticut@womeninbio.org.
|
Kathleen Adams
Entrepreneur in Residence
UCONN Ventures
|
Carrie Collins
Corporate Development
Rallybio
|
Lisa Delfini
Chief Financial Officer
Trevi Therapeutics
|
Carla Devillers
Chief Executive Officer
LeptoX Biopharma
|
Susan Gallipoli
Senior Director, Clinical Research Operations
Invicro
|
Anjelica Gonzalez
Professor
Yale University
|
Stephanie Jacoby
Board Chair and Manager, Founding CEO
Propria
|
Michelle Johnson
Chief Executive Officer
Metrum Research Group
|
Katherine Kayser-Bricker
Chief Scientific Officer
Halda Therapeutics
|
Lisa Sinclair
SVP, Corporate Operations
Arvinas
|
Erika Smith
Chief Executive Officer
ReNetX Bio
|
Susan Sobolov
President
RIGImmune
|
Program Co-founded by
|